Today's Date
Proleukin® and Rapamune® in Type 1 Diabetes Mellitus
(
IL2-RAPA
)
ITN Protocol #:
ITN018AI
Branded Name:
IL2-RAPA
ClinicalTrials.Gov ID:
NCT00525889Treatment Protocol #:
Therapeutic Area:
Type 1 Diabetes
Current Status:
Completed
Summary:
A Phase I Trial of Proleukin® and Rapamune® in Recent-onset Type 1 Diabetes Mellitus
Clinical Operations Manager
NIAID Project Manager
Rho Scientist
Study Personnel:
